Percutaneous treatment of peripheral vascular malformations with a mixture of polidocanol and CO2. Initial experience;Tratamiento percutáneo de las malformaciones vasculares periféricas con una mezcla de polidocanol y CO2. Experiencia inicial

Radiologia

Volumn 50, Issue 5, 2008, Pages 424-429

  Gorriz Gomez E ^a   Carreira, José Martín ^b,c  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Angiography; Embolization; Hemangioma; Therapeutic sclerotherapy; Vascular disease; Vascular malformations

Indexed keywords

CARBON DIOXIDE; CEFAZOLIN; HYDROCORTISONE SODIUM PHOSPHATE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; POLIDOCANOL;

ADOLESCENT; ADULT; AGED; ANGIOGRAPHY; ARTERIOGRAPHY; ARTICLE; CATHETER; CHILD; CLINICAL ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; EDEMA; FACE; FEMALE; HEMANGIOMA; HUMAN; IMAGING SYSTEM; LIP; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; SCLEROTHERAPY; TREATMENT OUTCOME;

EID: 60149093124     PISSN: 00338338     EISSN: 15781771     Source Type: Journal    
DOI: 10.1016/S0033-8338(08)76058-2     Document Type: Article

References (28)

1. Enjolras O. Les angiomes de l'enfant. La revue de pediatrie. 1982;6:361-8.
2. Finn HC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg. 1983;18:894-900.
3. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412-20.
4. Enjorlas O, Herbreteau D, Lemerchand F, Riche MC, Laurian C, Brette MD, et al. Hémangiomes et malformations vasculaires superficielles: classification. J Mal Vasc. 1992;17:2-19.
5. Bensahel H, Melchior B. Retentissement osseux des angiodysplasies. J Mal Vasc. 1992;17:73-6.
6. Enjolras O. Hemangiomes immatures. En: Enjolras O, Riché MC, editores. Hemangiomes et malformations vasculaires superficielles. Paris: Medsi/McGraw-Hill; 1990. p. 18-54.
7. Riché HC. Examens complementaires et moyens de diagnostic. En: Enjolras O, Riché HC, editores. Hemangiomes et malformations vasculaires superficielles. Paris: Mc Graw-Hill; 1990. p. 12-5.
8. Laurian C. Malformations vasculaires des membres. Place de la chirurgie vasculaire et réparatrice. J Mal Vasc. 1992;17:57-60.
9. Mitty HA, Kleiger B. Partial embolization of large peripheral hemangioma for pain control. Radiology. 1978;127:671-2.
10. Yakes WF. Extremity venous malformations diagnosis and management. Semin Intervent Radiol. 1994;11:332-9.
11. Rak KM, Yakes WF, Ray RL, Dreisbach JN, Parker SH, Luethke JM, et al. MR imaging of symptomatic peripheral vascular malformations. AJR Am J Roentgenol. 1992;159:107-12.
12. Górriz Gómez E, Carreira Villamor JM. Microespuma esclerosante con CO2, dispositivo de preparación y sus aplicaciones. Solicitud de Patente P200601995. Presentada el 25 de julio de 2006.
13. Lemarchand-Venencie F. Conduite a tenir devant un hémangiome du nourrisson. J Mal Vasc. 1992;17:33-40.
14. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. JVIR. 2004;15:431-45.
15. Konez O. Treatment of musculoskeletal vascular anomalies. Semin Musculoskelet Radiol. 2006;10:145-58.
16. Hideki H, Masakazu H, Hidenari A, Mitsuharu T, Kazusa H, Masato H. Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues. Radiographics. 2005;25:159-71.
17. Górriz E, Carreira JM, Reyes R, Pulido-Duque JM, Pardo MD, Romero A, et al. Tratamiento percutáneo de las malformaciones vasculares periféricas. Rev Clin Esp. 1998;198:565-70.
18. Rautio R, Saarinen J, Laranne J, Salenius JP, Keski Nisula L. Endovascular treatment of venous malformations in extremities: results of sclerotherapy and the quality of life after treatment. Acta Radiol. 2004;5:397-403.
19. Mendel T, Louis DS. Major vascular malformations of the upper extremity: long-term observation. J Hand Surg Am. 1997;22:302-6.
20. Jackson JE, Mansfield AO, Allison DJ. Treatment of high-flow vascular malformations by venous embolization aided by flow occlusion techniques. Cardiovasc Intervent Radiol. 1996;19:323-8.
21. Gomes AS. Embolization therapy of congenital arteriovenous malformations: use of alternate approaches. Radiology. 1994;190:191-8.
22. Osuga K, Hori S, Kitayoshi H, Khankan AA, Okada A, Sugiura T, et al. Embolization of high flow arteriovenous malformations: experience with use of superabsorbent polymer microspheres. J Vasc Interv Radiol. 2002;13: 1125-33.
23. Shimo T, Hidaka K, Yanagawa S, Kadota W, Kawakami S, Tsuchida H. Two episodes of cardiac arrest in a boy receiving sclerotherapy with polydocanol-a case report. Masui. 2005;54:57-9.
24. Feied CF, Jackson JJ, Brens TS, Bond OB, Fernando CE, Young VC, et al. Allergic reactions to polidocanol for vein sclerosis. Two case reports. J Dermatol Surg Oncol. 1994;20:466-8.
25. Cabrera Garrido, et al. Injectable microfoam containing a sclerosing agent. United States Patent 5,676,962. Foreing Application Priority Data June 23, 1993 Spain 9301430.
26. Cabrera J. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139:1494-6.
27. Redondo P, Cabrera J. Microfoam sclerotherapy. Semin Cutan Med Surg. 2005;24:175-83.
28. Hamel-Desnos C, Desnos P, Wollman J, Ouvry P, Mako S, Allaert F. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: Initial results. Dermatol Surg. 2003;29:1170-5